NanoViricides Inc. (NYSE AMERICAN: NNVC)
$2.03
+0.2450 ( +13.76% ) 683.5K
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.
Market Data
Open
$2.03
Previous close
$1.78
Volume
683.5K
Market cap
$24.34M
Day range
$1.75 - $2.08
52 week range
$1.00 - $3.59
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 61 | May 15, 2024 |
8-k | 8K-related | 16 | Apr 05, 2024 |
8-k | 8K-related | 20 | Feb 16, 2024 |
10-q | Quarterly Reports | 64 | Feb 14, 2024 |
8-k | 8K-related | 12 | Jan 19, 2024 |
def | Proxies and info statements | 2 | Dec 04, 2023 |
10-q | Quarterly Reports | 60 | Nov 14, 2023 |
8-k | 8K-related | 13 | Nov 07, 2023 |
10-k | Annual reports | 70 | Oct 13, 2023 |
nt | Quarterly Reports | 1 | Sep 28, 2023 |